Articles written by: Ash Reddy

Raymond James & Associates Has Trimmed By $6.41 Million Its Masco (MAS) Stake; Synnex (SNX)’s Sentiment Is 2.4

Raymond James & Associates Has Trimmed By $6.41 Million Its Masco (MAS) Stake; Synnex (SNX)’s Sentiment Is 2.4

Synnex Corp (SNX) investors sentiment increased to 2.4 in 2018 Q4. It’s up 1.11, from 1.29 in 2018Q3. The ratio is more positive, as 180 hedge funds opened new and increased stock positions, while 75 reduced and sold their stakes in Synnex Corp. The hedge funds in our database now […]

Albireo Pharma Inc. (ALBO) and AgeX Therapeutics Inc. (NYSEAMERICAN:AGE) Comparing side by side

Albireo Pharma Inc. (NASDAQ:ALBO) and AgeX Therapeutics Inc. (NYSEAMERICAN:AGE) compete against each other in the Biotechnology sector. We will compare them and contrast their analyst recommendations, profitability, risk, dividends, institutional ownership, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Albireo Pharma […]

Autus Asset Management Decreased Integrated Device Technology (IDTI) Position By $1.25 Million; Federal Signal (FSS)’s Sentiment Is 1.44

Autus Asset Management Decreased Integrated Device Technology (IDTI) Position By $1.25 Million; Federal Signal (FSS)’s Sentiment Is 1.44

Autus Asset Management Llc decreased Integrated Device Technology (IDTI) stake by 46.21% reported in 2018Q4 SEC filing. Autus Asset Management Llc sold 26,090 shares as Integrated Device Technology (IDTI)’s stock rose 1.09%. The Autus Asset Management Llc holds 30,365 shares with $1.47 million value, down from 56,455 last quarter. Integrated […]

Contrasting of BioLineRx Ltd. (BLRX) and OncoCyte Corporation (NYSEAMERICAN:OCX)

BioLineRx Ltd. (NASDAQ:BLRX) and OncoCyte Corporation (NYSEAMERICAN:OCX) have been rivals in the Biotechnology for quite some time. Below is a review of each business including various aspects such as institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per […]

Blackrock Has Lowered Its British Amern Tob Plc (BTI) Position; Dicerna Pharmaceuticals, Inc. (DRNA) Covered By 7 Bullish Analysts Last Week

Blackrock Has Lowered Its British Amern Tob Plc (BTI) Position; Dicerna Pharmaceuticals, Inc. (DRNA) Covered By 7 Bullish Analysts Last Week

Blackrock Inc decreased British Amern Tob Plc (BTI) stake by 19.35% reported in 2018Q4 SEC filing. Blackrock Inc sold 370,296 shares as British Amern Tob Plc (BTI)’s stock rose 6.28%. The Blackrock Inc holds 1.54M shares with $49.16 million value, down from 1.91 million last quarter. British Amern Tob Plc […]

Donaldson Capital Management Has Lifted Starbucks Com (SBUX) Stake; ESSILORLUXOTTICA AMERICAN DEPOSITARY REC (ESLOY) Sellers Decreased By 84.04% Their Shorts

Donaldson Capital Management Has Lifted Starbucks Com (SBUX) Stake; ESSILORLUXOTTICA AMERICAN DEPOSITARY REC (ESLOY) Sellers Decreased By 84.04% Their Shorts

Donaldson Capital Management Llc increased Starbucks Corp Com (SBUX) stake by 3.45% reported in 2018Q4 SEC filing. Donaldson Capital Management Llc acquired 16,931 shares as Starbucks Corp Com (SBUX)’s stock rose 6.18%. The Donaldson Capital Management Llc holds 508,000 shares with $32.72 million value, up from 491,069 last quarter. Starbucks […]

Raymond James Maintains $145 Target Price per Share On Johnson & Johnson (JNJ), Maintains Buy Rating; Profile of 2 Analysts Covering IDEXX Laboratories, Inc. (IDXX)

Raymond James Maintains $145 Target Price per Share On Johnson & Johnson (JNJ), Maintains Buy Rating; Profile of 2 Analysts Covering IDEXX Laboratories, Inc. (IDXX)

Among 2 analysts covering IDEXX Laboratories (NASDAQ:IDXX), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. IDEXX Laboratories had 2 analyst reports since November 2, 2018 according to SRatingsIntel. The rating was maintained by Bank of America with “Buy” on Friday, November 2. Canaccord Genuity maintained […]

EPS for Stifel Financial Corp. (SF) Expected At $1.19; Eastern Company (the (EML) Shorts Increased By 2.14%

EPS for Stifel Financial Corp. (SF) Expected At $1.19; Eastern Company (the (EML) Shorts Increased By 2.14%

Analysts expect Stifel Financial Corp. (NYSE:SF) to report $1.19 EPS on April, 29.They anticipate $0.04 EPS change or 3.48% from last quarter’s $1.15 EPS. SF’s profit would be $85.53M giving it 10.64 P/E if the $1.19 EPS is correct. After having $1.57 EPS previously, Stifel Financial Corp.’s analysts see -24.20% […]

EPS for Alliance Resource Partners, L.P. (ARLP) Expected At $0.68; Last Week CenturyLink, Inc. (CTL) Analysts

EPS for Alliance Resource Partners, L.P. (ARLP) Expected At $0.68; Last Week CenturyLink, Inc. (CTL) Analysts

Analysts expect Alliance Resource Partners, L.P. (NASDAQ:ARLP) to report $0.68 EPS on April, 29.They anticipate $0.13 EPS change or 23.64% from last quarter’s $0.55 EPS. ARLP’s profit would be $87.30M giving it 7.49 P/E if the $0.68 EPS is correct. After having $0.69 EPS previously, Alliance Resource Partners, L.P.’s analysts […]

Chatham Capital Group Has Increased Jpmorgan Chase & Co (JPM) Holding; Equity Lifestyle Properties Has 1.26 Sentiment

Chatham Capital Group Has Increased Jpmorgan Chase & Co (JPM) Holding; Equity Lifestyle Properties Has 1.26 Sentiment

Chatham Capital Group Inc increased Jpmorgan Chase & Co (JPM) stake by 310.35% reported in 2018Q4 SEC filing. Chatham Capital Group Inc acquired 30,135 shares as Jpmorgan Chase & Co (JPM)’s stock declined 6.08%. The Chatham Capital Group Inc holds 39,845 shares with $3.89M value, up from 9,710 last quarter. […]